Codexis (CDXS) to Release Quarterly Earnings on Thursday

Codexis (NASDAQ:CDXS) is set to release its earnings data after the market closes on Thursday, August 8th. Analysts expect Codexis to post earnings of ($0.26) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Codexis Price Performance

Codexis stock opened at $3.22 on Wednesday. The company has a fifty day simple moving average of $3.25 and a 200-day simple moving average of $3.24. The firm has a market capitalization of $227.20 million, a price-to-earnings ratio of -3.46 and a beta of 2.12. The company has a quick ratio of 3.63, a current ratio of 3.71 and a debt-to-equity ratio of 0.35. Codexis has a 52-week low of $1.45 and a 52-week high of $4.91.

Analyst Upgrades and Downgrades

CDXS has been the topic of several research reports. Cantor Fitzgerald assumed coverage on shares of Codexis in a research report on Thursday, May 30th. They set an “overweight” rating and a $11.00 price target on the stock. Jefferies Financial Group started coverage on shares of Codexis in a report on Monday, June 3rd. They set a “buy” rating and a $5.00 target price on the stock. Finally, Benchmark restated a “buy” rating and issued a $9.00 price target on shares of Codexis in a research note on Friday, May 3rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $7.33.

Codexis Company Profile

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.